{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:39:23Z","timestamp":1791823163014,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007234","name":"University of Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009750","name":"Medical Center, University of Rochester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008136","name":"Case Western Reserve University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007052","name":"Memorial Sloan Kettering Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007312","name":"Cleveland Clinic Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007263","name":"Virginia Polytechnic Institute and State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019704","name":"Konkuk University Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA18086 8"],"award-info":[{"award-number":["U10CA18086 8"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1 U10 CA180822"],"award-info":[{"award-number":["1 U10 CA180822"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011531","name":"University of Alabama","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018491","name":"Health Sciences, University of Arizona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008102","name":"University of Cincinnati","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007920","name":"University of Massachusetts Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006710","name":"Wayne State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006668","name":"Oregon Health and Science University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010249","name":"School of Medicine, Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013965","name":"Eastern Virginia Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013965","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ygyno.2023.03.018","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T17:03:12Z","timestamp":1683219792000},"page":"130-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology\/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study"],"prefix":"10.1016","volume":"173","author":[{"given":"Tiffany Y.","family":"Sia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Tew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Purdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis S.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Menzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Lovecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Bookman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna G.","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Mutch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Gershenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnansu S.","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Wenham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea E.","family":"Wahner Hendrickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger B.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeles Alvarez","family":"Secord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Van Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M.","family":"Lichtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2023.03.018_bb0005","series-title":"SEER Cancer Statistics Review","volume":"1975","author":"Howlader","year":"2008"},{"issue":"24","key":"10.1016\/j.ygyno.2023.03.018_bb0010","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1200\/JCO.2014.55.3073","article-title":"Breast and ovarian cancer in the older woman","volume":"32","author":"Tew","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.018_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11864-012-0216-2","article-title":"Considerations in the surgical Management of Ovarian Cancer in the elderly","volume":"14","author":"Langstraat","year":"2013","journal-title":"Curr. Treat. Options in Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2023.03.018_bb0020","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/sj.bjc.6604298","article-title":"Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival","volume":"98","author":"Wright","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.018_bb0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1200\/JCO.2002.20.1.173","article-title":"Variations in the use of chemotherapy for elderly patients with advanced ovarian Cancer: a population-based study","volume":"20","author":"Sundararajan","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2023.03.018_bb0030","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jgo.2016.07.008","article-title":"Ovarian cancer in the older woman","volume":"7","author":"Tew","year":"2016","journal-title":"J. Geriatr. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.018_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ygyno.2023.03.018_bb0040","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jnci\/92.9.699","article-title":"Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results","volume":"92","author":"Piccart","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"17","key":"10.1016\/j.ygyno.2023.03.018_bb0045","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.03.018_bb0050","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/cncr.11110","article-title":"Can older cancer patients tolerate chemotherapy? A prospective pilot study","volume":"97","author":"Chen","year":"2003","journal-title":"Cancer."},{"issue":"24","key":"10.1016\/j.ygyno.2023.03.018_bb0055","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1200\/JCO.2002.05.088","article-title":"Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast Cancer","volume":"20","author":"Du","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.03.018_bb0060","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/gyno.2002.6759","article-title":"Age contrasts in clinical characteristics and pattern of Care in Patients with epithelial ovarian Cancer","volume":"86","author":"Bruchim","year":"2002","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.018_bb0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/1097-0142(19940115)73:2<377::AID-CNCR2820730223>3.0.CO;2-#","article-title":"National survey of ovarian carcinoma IV: patterns of care and related survival for older patients","volume":"73","author":"Hightower","year":"1994","journal-title":"Cancer."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.018_bb0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ygyno.2018.02.017","article-title":"Treatment and outcome of elderly patients with advanced stage ovarian cancer: a nationwide analysis","volume":"149","author":"Schuurman","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.03.018_bb0075","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ygyno.2016.11.033","article-title":"Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - an NRG oncology\/gynecologic oncology group study","volume":"144","author":"von Gruenigen","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2023.03.018_bb0080","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jamaoncol.2021.0696","article-title":"Efficacy and safety of first-line single-agent carboplatin vs carboplatin plus paclitaxel for vulnerable older adult women with ovarian Cancer: a GINECO\/GCIG randomized clinical trial","volume":"7","author":"Falandry","year":"2021","journal-title":"JAMA Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2023.03.018_bb0085","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2008.19.1684","article-title":"Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a phase III trial of the gynecologic Cancer intergroup","volume":"27","author":"Bookman","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.018_bb0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/JCO.2005.01.2757","article-title":"Comparison of CA-125 and standard definitions of progression of ovarian cancer in the intergroup trial of cisplatin and paclitaxel versus cisplatin and cyclophosphamide","volume":"24","author":"Rustin","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"25","key":"10.1016\/j.ygyno.2023.03.018_bb0095","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study","volume":"29","author":"Hurria","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.03.018_bb0100","first-page":"292","article-title":"Chemotherapy of ovarian cancer in elderly patients","volume":"12","author":"Troso-Sandoval","year":"2015","journal-title":"Cancer Biol. Med."},{"issue":"16","key":"10.1016\/j.ygyno.2023.03.018_bb0105","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1200\/JCO.18.01568","article-title":"Randomized trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: an NRG oncology\/gynecologic oncology group study","volume":"37","author":"Walker","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2023.03.018_bb0110","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S1470-2045(15)00086-8","article-title":"Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial","volume":"16","author":"Oza","year":"2015","journal-title":"Lancet Oncol."},{"issue":"26","key":"10.1016\/j.ygyno.2023.03.018_bb0115","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","article-title":"Incorporation of bevacizumab in the primary treatment of ovarian cancer","volume":"365","author":"Burger","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.ygyno.2023.03.018_bb0120","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","article-title":"Olaparib plus bevacizumab as first-line maintenance in ovarian Cancer","volume":"381","author":"Ray-Coquard","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2023.03.018_bb0125","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/ijgc-00009577-200311000-00002","article-title":"Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5","volume":"13","author":"Bookman","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.018_bb0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ygyno.2012.04.019","article-title":"Frailty: an outcome predictor for elderly gynecologic oncology patients","volume":"126","author":"Courtney-Brooks","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.018_bb0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ygyno.2015.01.532","article-title":"Frailty index predicts severe complications in gynecologic oncology patients","volume":"137","author":"Uppal","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.018_bb0140","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ygyno.2017.07.126","article-title":"Functional not chronologic age: frailty index predicts outcomes in advanced ovarian cancer","volume":"147","author":"Kumar","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.018_bb0145","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2018.12.025","article-title":"Frailty in ovarian cancer identified the need for increased postoperative care requirements following cytoreductive surgery","volume":"153","author":"Yao","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.018_bb0150","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ygyno.2020.08.024","article-title":"Effect of frailty on postoperative readmissions and cost of care for ovarian cancer","volume":"159","author":"Sia","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.03.018_bb0155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2015.03.052","article-title":"Delay in chemotherapy administration impacts survival in elderly patients with epithelial ovarian cancer","volume":"137","author":"Joseph","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2023.03.018_bb0160","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.17517","article-title":"Trends in primary treatment and median survival among women with advanced-stage epithelial ovarian Cancer in the US from 2004 to 2016","volume":"3","author":"Knisely","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"28","key":"10.1016\/j.ygyno.2023.03.018_bb0165","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2023.03.018_bb0170","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0923-7534(20)31479-4","article-title":"How long should first-line chemotherapy continue?","volume":"10","author":"Bertelsen","year":"1999","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.018_bb0175","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ygyno.2005.10.031","article-title":"Two for good measure: six versus eight cycles of carboplatin and paclitaxel as adjuvant treatment for epithelial ovarian cancer","volume":"100","author":"Dizon","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2023.03.018_bb0180","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/jjco\/hyn034","article-title":"Are three additional cycles of chemotherapy useful in patients with advanced-stage epithelial ovarian cancer after a complete response to six cycles of intravenous adjuvant paclitaxel and carboplatin?","volume":"38","author":"Kim","year":"2008","journal-title":"Jpn. J. Clin. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823001658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823001658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:57:55Z","timestamp":1777474675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823001658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":36,"alternative-id":["S0090825823001658"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.03.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology\/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}